- Biomerica's **Fortel® Kidney Test** has received approval for home use from the **United Arab Emirates (UAE) Ministry of Health and Prevention**.  **[73290_4a21bf7535b9453183fbeaad440d93c0_1]** 
- This rapid, **10-minute** diagnostic test detects early kidney damage by identifying low levels of albumin in urine.  **[73290_4a21bf7535b9453183fbeaad440d93c0_0]** **[73290_4a21bf7535b9453183fbeaad440d93c0_1]** 
- The approval is particularly relevant for the UAE, where **diabetes** affects approximately **one in four UAE nationals** and **hypertension** has an overall prevalence of about **31%**, both being major risk factors for chronic kidney disease.  **[73290_4a21bf7535b9453183fbeaad440d93c0_0]** **[73290_4a21bf7535b9453183fbeaad440d93c0_1]** 
- This regulatory milestone expands access to diagnostic tools and strengthens Biomerica's presence in the Middle East, with the test planned for availability in pharmacies, clinics, and hospitals throughout the UAE.  **[73290_4a21bf7535b9453183fbeaad440d93c0_1]**

Biomerica's Fortel® Kidney Test Approved for Home Use in UAE

- Biomerica reported net sales of **$5.3 million** for the fiscal year ended May 31, 2025, a slight decrease from **$5.4 million** in the prior year, primarily due to global tariff-related uncertainties and a shift in product mix.  **[73290_cb4e7b569cdd48c1918889bf427a2e3f_0]** 
- The company significantly improved its financial efficiency, reducing operating expenses by over **$1.3 million** and improving its operating loss to **$5.1 million** from **$6.4 million** year-over-year.  **[73290_cb4e7b569cdd48c1918889bf427a2e3f_0]**  Cash used in operating activities also improved to **$3.8 million** from **$5.3 million** in the prior year.  **[73290_cb4e7b569cdd48c1918889bf427a2e3f_0]** 
- Key strategic advancements include the American Medical Association issuing a Proprietary Laboratory Analyses (PLA) code for Biomerica’s inFoods® IBS test, advancing its reimbursement pathway, and the introduction of a new patient self-collection system for inFoods® IBS to expand access.  **[73290_cb4e7b569cdd48c1918889bf427a2e3f_0]** **[73290_cb4e7b569cdd48c1918889bf427a2e3f_1]**

BIOMERICA (BMRA)